ADC Therapeutics(ADCT) - 2024 Q4 - Earnings Call Transcript

ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Conference Call March 27, 2025 8:30 AM ET Company Participants Marcy Graham - Investor Relations Officer Ameet Mallik - Chief Executive Officer Pepe Carmona - Chief Financial Officer Conference Call Participants Eric Schmidt - Cantor Kelly Shi - Jefferies Michael Schmidt - Guggenheim Sudan Loganathan - Stephens Operator Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this tim ...